200 related articles for article (PubMed ID: 12923132)
1. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium.
Roopa BA; Loganath A; Singh K
Hum Reprod; 2003 Sep; 18(9):1809-19. PubMed ID: 12923132
[TBL] [Abstract][Full Text] [Related]
2. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
3. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.
Burton KA; Henderson TA; Hillier SG; Mason JI; Habib F; Brenner RM; Critchley HO
Hum Reprod; 2003 Dec; 18(12):2610-7. PubMed ID: 14645180
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
[TBL] [Abstract][Full Text] [Related]
5. Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis.
Laoag-Fernandez JB; Maruo T; Pakarinen P; Spitz IM; Johansson E
Hum Reprod; 2003 Apr; 18(4):694-9. PubMed ID: 12660258
[TBL] [Abstract][Full Text] [Related]
6. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
7. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
8. Endometrial angiogenic response in Norplant users.
Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
[TBL] [Abstract][Full Text] [Related]
9. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
10. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
[TBL] [Abstract][Full Text] [Related]
11. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy.
Varila E; Wahlström T; Rauramo I
Fertil Steril; 2001 Nov; 76(5):969-73. PubMed ID: 11704119
[TBL] [Abstract][Full Text] [Related]
12. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
13. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
Selim MF; Hussein AF
Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
[TBL] [Abstract][Full Text] [Related]
14. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery.
Jones RL; Critchley HO
Hum Reprod; 2000 Aug; 15 Suppl 3():162-72. PubMed ID: 11041232
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Cihangir U; Ebru A; Murat E; Levent Y
Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
[TBL] [Abstract][Full Text] [Related]
16. The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.
Pakarinen PI; Lähteenmäki P; Lehtonen E; Reima I
Hum Reprod; 1998 Jul; 13(7):1846-53. PubMed ID: 9740437
[TBL] [Abstract][Full Text] [Related]
17. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
18. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
20. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system.
Rutanen EM; Salmi A; Nyman T
Mol Hum Reprod; 1997 Sep; 3(9):749-54. PubMed ID: 9357999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]